Pan-cancer proteogenomics expands the landscape of therapeutic targets

Sara R. Savage(Baylor College of Medicine), Bing Zhang(Baylor Genetics), Bo Wen(University of Washington), Paul Shafer(Baylor College of Medicine), Valentina Hoyos(Baylor College of Medicine), Xinpei Yi(Chinese Academy of Sciences), Jonathan T. Lei(Baylor College of Medicine), Lauren K. Somes(Baylor College of Medicine), Hongwei Zhao(Hainan University), Yuxing Liao(Baylor College of Medicine), Yongchao Dou(Baylor College of Medicine), Qiang Gao(Fudan University), Daming Gao(Westlake University), Tobie D. Lee(National Institutes of Health), Zile Fu(Ministry of Education), Zhiao Shi(Vanderbilt University), Eric J. Jaehnig(Baylor College of Medicine)
Cell
June 24, 2024
10.1016/j.cell.2024.05.039
Cited by 105

Related Papers

The oyster genome reveals stress adaptation and complexity of shell formation
|Nature|2012|2.3k
WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013
|Nucleic Acids Research|2013|1.6k
Chromatin Potential Identified by Shared Single-Cell Profiling of RNA and Chromatin
|Cell|2020|1.2k
Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
|Cell|2019|1.2k
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
|Cell|2016|1.1k